Initiating Buprenorphine - A Certificate Training Program
Tracking # 20-1114284
$99999.00
There are no ratings for this course
Learn more Educator AMERICAN PHARMACISTS ASSOCIATION
CE Broker Reporting Reported automatically
Method Computer-Based Training
Course overview
0202-0000-23-399-H08-P This comprehensive, webinar-based training program is designed to meet the Substance Abuse and Mental Health Services Administration (SAMHSA) training requirements for Medication Access and Training Expansion (MATE) Act of 2023. Pharmacists and physicians initiation medications for opioid use disorder will learn about screening, non-pharmacologic and pharmacologic management and communication and addressing barriers related to management of pain and substance use disorders.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Pharmacy
Pharmacist
8h
General